Associations of different insulin resistance indices with the erectile dysfunction incidence: a cross-sectional analysis of the NHANES 2001–2004 Authors: Yang Sun, Minzhi Zhou, Min Yin, Libin Zhou, Zeming Weng Published: 2025 ABSTRACT BackgroundInsulin resistance (IR) has been related to erectile dysfunction (ED). IR indices refer to calculation-based indices that estimate insulin sensitivity using routine clinical or biochemical parameters. However, there are fewer studies comparing the advantages of the relationship between different IR indices and ED. This study aimed to investigate the relationship between IR indices and the presence of ED.MethodsData from the National Health and Nutrition Examination Survey (NHANES) 2001–2004 were analyzed. The associations of estimated glucose disposal rate (eGDR), triglyceride glucose (TyG) index, Homeostatic Model Assessment of IR (HOMA-IR), and TyG-body mass index (TyG-BMI) with ED were evaluated using weighted logistic regression and restricted cubic spline analysis.ResultsThere were 1,737 subjects examined. Only the eGDR was an independent predictor for ED in the model adjusted for all covariates in the weighted logistic regression analysis. Lower eGDR was associated with an increased risk of ED, even following covariate adjustment [continuous eGDR: odds ratio (OR) =0.91, 95% confidence interval (CI): 0.83–0.99, P=0.03; quartile 3 (Q3) vs. quartile 1 (Q1): OR =0.59, 95% CI: 0.37–0.95, P=0.03]. Restricted cubic spline analysis indicated a nonlinear relationship between eGDR and ED (P for nonlinearity <0.001). Subgroup analyses consistently showed that higher eGDR levels were linked to a lower risk of ED in all subgroups, with significant interactions observed in education level and physical activity subgroups.ConclusionseGDR was inversely associated with an increased risk of ED, suggesting that it might be as a potential and reliable predictor for ED incidence. Highlight box Key findings • Higher estimated glucose disposal rate (eGDR) was inversely associated with erectile dysfunction (ED) prevalence after adjustment for key confounders, suggesting a potential link between insulin resistance (IR)-related metabolic status and ED. What is known and what is new? • IR contributes to ED through mechanisms involving endothelial dysfunction and metabolic dysregulation, but most evidence has focused on traditional markers such as Homeostatic Model Assessment of IR. • This study is the first to investigate the relationship between eGDR and ED in a large U.S. cohort by comparing multiple IR indices. What is the implication, and what should change now? • IR markers, particularly eGDR, may help identify men at higher risk of ED. Future prospective studies are needed to validate these associations and clarify how such markers can be applied in clinical assessment and risk stratification. Introduction Erectile dysfunction (ED) is a common condition that substantially impairs men’s quality of life worldwide. It is defined as the consistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance (1). ED shows an age-related prevalence increase. According to the Massachusetts Male Aging Study (MMAS), 52% of men aged 40–70 years experience mild to moderate ED, and nearly all men over 70 years are affected (2). Despite advancements in medical treatments, ED remains a complex issue due to its multifactorial etiology, which includes physiological, psychological, and lifestyle factors such as obesity, physical inactivity, and smoking, as well as metabolic conditions like diabetes, hypertension, hyperlipidemia, and depression (3-6). Early recognition and intervention of risk factors are crucial for enhancing sexual function and overall quality of life. Diabetes is one of the most common risk factors for ED, tripling its risk by damaging vascular and neural systems. Studies confirm that both established and newly diagnosed diabetes, as well as impaired glucose metabolism, are linked to more severe ED (7,8). Insulin resistance (IR), characterized by a diminished cellular response to insulin, results in impaired glucose metabolism and elevated blood sugar levels, and has emerged as a significant factor in the pathogenesis of ED (9). Various studies have established a link between IR and ED, suggesting that metabolic disturbances associated with IR can lead to endothelial dysfunction and disrupt the subcellular signaling pathways necessary for nitric oxide (NO) production (10). Understanding this connection is vital for early identification and treatment of men at risk of ED, particularly those with metabolic syndrome and type 2 diabetes mellitus (DM). However, the current gold method for assessing IR is the hyperinsulinemic-euglycemic clamp; nevertheless, its invasive nature and high cost restrict its widespread clinical application (11). So, more convenient and non-invasive indices have been developed to evaluate IR. The Homeostatic Model Assessment of IR (HOMA-IR) index, for instance, has been proposed as an early predictive marker of both endothelial dysfunction and non-organic ED, even when fasting plasma insulin and glucose levels are within normal ranges (12). Nonetheless, circulating insulin concentrations are not routinely measured in primary care, prompting the development of simpler and more feasible alternative indices such as the triglyceride glucose (TyG) index (13), TyG-body mass index (TyG-BMI) index (14), and estimated glucose disposal rate (eGDR) (15). Among these indices, each reflects distinct aspects of glucose and lipid metabolism, insulin sensitivity, and body composition, thereby offering complementary perspectives on metabolic health. In particular, these indices provide an opportunity to assess the metabolic contribution to ED beyond the presence of overt diabetes, capturing early subclinical alterations in insulin signaling and endothelial function. Recent evidence supports the TyG index as an economical and convenient marker for the diagnosis and monitoring of ED (16,17). However, there has been limited research on the relationships between TyG-BMI, eGDR, and ED, and a lack of comparative assessments of different IR surrogates within the same population. This study sought to investigate the links between the prevalence of ED and various IR surrogate markers using data from the National Health and Nutrition Examination Survey (NHANES) 2001–2004. The primary objective was to identify valuable predictors of ED incidence. We present this article in accordance with the STROBE reporting checklist (available at https://tau.amegroups.com/article/view/10.21037/tau-2025-665/rc). Methods Study design and participants The NHANES project biennially chooses the typical U.S. adults for assessing and evaluating their nutritional and health status. It gathers extensive data, including demographic and dietary details, questionnaire responses, laboratory tests, and medical examinations. As NHANES erectile function questionnaire data were only available during 2001–2004, our work focused on this timeframe, including 4,954 males (≥20 years). Following excluding subjects without information on the eGDR record, ED information, and covariates, 1,737 participants were used for the following analysis (Figure 1). The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. Flow chart of the study participants. ED, erectile dysfunction; IR, insulin resistance; NHANES, National Health and Nutrition Examination Survey. IR surrogates This study utilized several surrogates for IR, including HOMA-IR, eGDR, TyG index, and TyG-BMI. HOMA-IR was derived using the formula: [fasting glucose (mmol/L) × fasting insulin (µU/mL)]/22.5 (18). The eGDR (mg/kg/min) was calculated as 21.158 − [0.09 × waist circumference (cm)] − [3.407 × hypertension status (present =1; absent =0)] − [0.551 × glycated hemoglobin (%)] (19). Hypertension was defined as either: (I) systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg; (II) use of antihypertensive medication; or (III) self-reported hypertension diagnosis (20). TyG index was computed using the equation: ln[fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2] (20). Additionally, TyG-BMI was obtained by multiplying the TyG index value by BMI (kg/m2) (21). These indices were selected because they represented different metabolic dimensions of IR. HOMA-IR reflects hepatic insulin sensitivity and β-cell function, TyG index and TyG-BMI are lipid-glucose composite indices that capture peripheral IR, and eGDR incorporates glycemic control, blood pressure, and central adiposity to estimate whole-body insulin sensitivity. Outcome variable ED was assessed using a single-item questionnaire adapted from the MMAS (22), which asked, “How would you describe your ability to get and keep an erection adequate for satisfactory intercourse?”. The response options were “always or almost always”, “usually”, “sometimes”, or “never”. Participants who answered “sometimes” or “never” were classified into the ED group, while those who responded “usually” or “always or almost always” were placed in the non-ED group. This method’s reliability is comparable to the International Index of Erectile Function (IIEF) (22). Covariate Participants provided data on age, race (classified as Mexican American, non-Hispanic White, non-Hispanic Black, other Hispanic, or other), marital status, education level (below, equivalent to, or above high school), family poverty-to-income ratio (PIR), alcohol intake (non-drinker, 1–<5, 5–<10, or 10+ drinks/month), smoking status (defined by having smoked at least 100 cigarettes in their lifetime), and physical activity (defined by having moderate or vigorous activity) through surveys. BMI was measured during the survey examination. Laboratory tests were performed on serum samples collected at the mobile examination center and analyzed at the National Center for Environmental Health. DM was defined by (I) hemoglobin A1c (HbA1c) level ≥6.5%; (II) fasting plasma glucose ≥126 mg/dL; (III) use of antidiabetic medications; or (IV) a diabetes diagnosis. Cardiovascular disease (CVD) was defined by meeting any of the following criteria: (I) diagnosis of congestive heart failure; (II) diagnosis of coronary heart disease (CHD); (III) diagnosis of angina pectoris; (IV) diagnosis of myocardial infarction; or (V) diagnosis of stroke, all based on affirmative responses to being informed of these conditions by a health professional. Hyperlipidemia was defined by triglyceride levels ≥150 mg/dL, high-density lipoprotein (HDL) levels <40 mg/dL, or a history of hyperlipidemia diagnosis and/or use of lipid-lowering medications (23). Statistical analysis In accordance with NHANES’s complex survey design and NCHS recommendations, we used appropriate weighting techniques to ensure accurate results. Baseline characteristics were classified into two groups: with or without ED. Continuous data were presented as mean ± standard deviation (SD). Categorical data were represented as counts (weighted proportions). To control the confounders, three weighted logistic regression models were applied: Model 1 (unadjusted), Model 2 (adjusted for age, race, marital status, PIR, and education level), and Model 3 (adjusted for age, race, marital status, PIR, education level, BMI, smoking status, alcohol intake, DM, CVD, hyperlipidemia, and physical activity). Weighted logistic regression analyses were conducted to evaluate the association of IR surrogates with ED, with results presented as odds ratios (ORs) and 95% confidence intervals (CIs). Three nodes, representing the 25th, 50th, and 75th percentiles of eGDR distribution, were selected. Subgroup analyses were performed to evaluate effect modification in the eGDR levels and ED association. Statistical significance was set at P<0.05 (two-tailed). Analyses were performed using R version 4.3.0. Results Baseline characteristics Altogether 1,737 participants were included in this study. Basic subject features are shown in Table 1. About 480 (19%) of the participants had ED. Notably, participants with ED were older, more likely to have a partner, possess a lower education level, exhibit an increased BMI, and be smokers. Additionally, those with ED tended to have higher incidences of DM, CVD, and hyperlipidemia, engage in no physical activity, have lower eGDR level and higher levels of HOMA-IR, TyG index, and TyG-BMI. Table 1Baseline characteristics of participants with or without EDCharacteristicsOverall (n=1,737, 100%)No ED (n=1,257, 81%)ED (n=480, 19%)P valueAge (years)44.6±15.740.8±13.460.4±14.8<0.001Marital status<0.001 Single523 [29]411 [32]112 [20] With a partner1,214 [71]846 [68]368 [80]Race0.072 Non-Hispanic White949 [74]663 [73]286 [80] Mexican American375 [8.1]266 [8.4]109 [7.0] Non-Hispanic Black305 [9.9]246 [11]59 [7.0] Other Hispanic56 [3.5]38 [3.6]18 [3.3] Other52 [4.3]44 [4.8]8 [2.3]Education level<0.001 Above high school825 [55]626 [57]199 [50] Under high school481 [16]293 [14]188 [25] High school or equivalent431 [28]338 [29]93 [25]Family PIR3.24±1.563.27±1.573.15±1.540.3BMI (kg/m2)28.2±5.327.9±5.129.2±6.30.010Smoking status1,027 [57]682 [54]345 [72]<0.001Alcohol intake0.008 1–<5 drinks/month929 [52]663 [52]266 [51] 5–<10 drinks/month156 [10]133 [11]23 [5.5] 10+ drinks/month352 [22]260 [22]92 [22] Non-drinker300 [16]201 [15]99 [22]DM210 [9.1]83 [5.1]127 [26]<0.001CVD209 [8.2]79 [4.7]130 [23]<0.001Hyperlipidemia1,043 [59]712 [56]331 [72]<0.001Physical activity1,096 [69]821 [70]275 [63]0.037HOMA-IR3.3±4.23.0±3.34.6±6.7<0.001TyG index8.81±0.698.75±0.679.07±0.73<0.001TyG-BMI249±56245±53266±65<0.001eGDR (mg/kg/min)7.94±2.488.30±2.306.42±2.63<0.001All values are presented as mean ± SD or as count [weighted proportion]. BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; ED, erectile dysfunction; eGDR, estimated glucose disposal rate; PIR, poverty-to-income ratio; SD, standard deviation; TyG, triglyceride glucose; TyG-BMI, triglyceride glucose-body mass index. Baseline characteristics of participants with or without ED All values are presented as mean ± SD or as count [weighted proportion]. BMI, body mass index; CVD, cardiovascular disease; DM, diabetes mellitus; ED, erectile dysfunction; eGDR, estimated glucose disposal rate; PIR, poverty-to-income ratio; SD, standard deviation; TyG, triglyceride glucose; TyG-BMI, triglyceride glucose-body mass index. Associations between different IR indices and ED Table 2 presents the association between IR indices and ED by the logistic regression analysis with three adjusted models. HOMA-IR, TyG index, and TyG-BMI were significantly associated with ED in Models 1 and 2, but not in Model 3. eGDR was inversely associated with ED risk. The protective effect weakened across models but remained significant in Model 3 (P=0.03). This result demonstrated that eGDR had a persistent protective effect of ED. When eGDR was divided into quartiles, the ED risk of subjects in quartile 3 (Q3) decreased by approximately 41% (95% CI: 0.37–0.95; P=0.03) in comparison with quartile 1 (Q1). Figure 2 illustrates the relation of eGDR with the risk of ED using RCS curves, indicating a significant nonlinear relationship (P<0.001). Table 2Relationship between IR indices and the risk of EDCharacteristicsModel 1Model 2Model 3OR95% CIP valueOR95% CIP valueOR95% CIP valueHOMA-IR1.081.03–1.130.0021.081.03–1.130.0021.020.98–1.070.30TyG index1.871.51–2.33<0.0011.611.21–2.130.0021.340.90–2.000.14TyG-BMI1.011.00–1.01<0.0011.011.00–1.02<0.0011.011.00–1.020.11eGDR0.740.70–0.78<0.0010.840.78–0.90<0.0010.910.83–0.990.03eGDR quartile Q1–––––– Q20.450.35–0.58<0.0010.680.45–1.030.070.890.57–1.390.60 Q30.260.19–0.37<0.0010.410.27–0.61<0.0010.590.37–0.950.03 Q40.120.08–0.18<0.0010.450.25–0.810.010.860.43–1.720.60 P for trend<0.001<0.0010.20Model 1: unadjusted. Model 2: adjusted for age, race, marital status, PIR, and education level. Model 3: adjusted for age, race, marital status, PIR, education level, BMI, smoking status, alcohol intake, DM, CVD, hyperlipidemia, and physical activity. BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; DM, diabetes mellitus; ED, erectile dysfunction; eGDR, estimated glucose disposal rate; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; IR, insulin resistance; OR, odds ratio; PIR, poverty-to-income ratio; TyG, triglyceride glucose; TyG-BMI, triglyceride glucose-body mass index. Relationship between IR indices and the risk of ED Model 1: unadjusted. Model 2: adjusted for age, race, marital status, PIR, and education level. Model 3: adjusted for age, race, marital status, PIR, education level, BMI, smoking status, alcohol intake, DM, CVD, hyperlipidemia, and physical activity. BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; DM, diabetes mellitus; ED, erectile dysfunction; eGDR, estimated glucose disposal rate; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; IR, insulin resistance; OR, odds ratio; PIR, poverty-to-income ratio; TyG, triglyceride glucose; TyG-BMI, triglyceride glucose-body mass index. Restricted cubic spline curve illustrating the association between eGDR and the risk of ED. The red lines depict the ORs, while the blue shaded areas indicate the 95% CIs. The model adjustments include age, race, marital status, PIR, education level, BMI, smoking status, alcohol intake, DM, CVD, hyperlipidemia, and physical activity. BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; DM, diabetes mellitus; ED, erectile dysfunction; eGDR, estimated glucose disposal rate; OR, odd ratio; PIR, poverty-to-income ratio. Subgroup analysis Subgroup analysis was conducted to evaluate the consistency of the association between eGDR and ED across different subgroups, including age, race, marital status, PIR, education level, BMI, smoking status, alcohol intake, DM, CVD, hyperlipidemia, and physical activity. The results indicated that, within each subgroup, participants with higher eGDR levels consistently exhibited a lower risk of ED (Figure 3). Additionally, significant interactions were observed across the subgroups of education level and physical activity. Stratified associations between eGDR and ED. BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; ED, erectile dysfunction; eGDR, estimated glucose disposal rate; OR, odds ratio; PIR, poverty-to-income ratio. Discussion This is the first study to evaluate the association between the various IR indices and ED. Multivariate regression models adjusted for confounders demonstrated that the eGDR was associated with a lower risk of ED. Subgroup analyses further indicated participants with higher eGDR levels consistently exhibited a lower risk of ED in each subgroup. Penile erection represents a multifaceted neurovascular process that depends on the coordinated function of vascular, neurological, psychological, hormonal, and interpersonal factors (24). Vascular factors significantly impact ED due to the specific vascular network of the penis (25). Consequently, ED is often linked not only to age but also to conditions such as obesity, physical inactivity, diabetes, hypertension, dyslipidemia, and CVD (26,27). IR plays a pivotal role in the development of ED by inducing endothelial dysfunction and structural vascular abnormalities (28,29). Studies in insulin-resistant obese animal models have shown that IR upregulates endothelin-b receptor expression, thereby promoting increased production of reactive oxygen species, endothelial dysfunction, and vasoconstriction in erectile tissue (30,31). Endothelial dysfunction reduces NO production, which results in ED (32). Previous studies have demonstrated that IR patients exhibit lower scores on the IIEF, predicting ED after adjusting for confounding factors (33). Although the glucose clamp technique is considered the gold standard for assessing IR, its clinical utility is limited due to its invasive nature and high cost. Surrogate markers such as the HOMA-IR, which uses fasting glucose and insulin levels, show strong correlation with clamp-measured IR (34). Studies have shown that HOMA-IR has a predictive ability for ED with an AUC of 0.759 (12). Multivariate logistic regression analysis identified HOMA-IR ≥3 as a strong predictor of ED (33). Our study confirmed significant differences in HOMA-IR between ED and non-ED populations. However, the main limitation of HOMA-IR might be the challenges in insulin testing. Recent studies have proposed the TyG index, which is determined by fasting glucose and triglyceride levels, may be a better alternative IR marker to HOMA-IR (35,36). Systematic reviews and meta-analyses further support its value as a diagnostic and prognostic tool across a range of cardiovascular and metabolic conditions (37,38). Yilmaz et al. reported that TyG had a significant inverse correlation with IIEF-5 scores, noting elevated TyG index values among individuals with ED (17). Another study found significantly higher TyG index levels in ED cases compared to controls, associating each unit increase in TyG index with a 25% increase in ED prevalence (39,40). Consistent with these findings, our analysis also confirmed higher TyG index levels in the ED group. A more recently developed metric, the eGDR, offers a non-invasive and clinically feasible alternative for assessing IR (41). Derived from waist circumference, HbA1c, and hypertension status, eGDR demonstrates strong agreement with the hyperinsulinemic-euglycemic clamp technique (42,43) and has been associated with adverse outcomes, including coronary artery disease, stroke, and all-cause mortality (44,45). In the present study, eGDR emerged as a significant predictor of ED, integrating both biochemical and clinical parameters for a holistic risk evaluation. To our knowledge, this is the first investigation to establish a link between eGDR and ED. Subgroup analyses revealed consistent negative associations between eGDR and ED risk, with significant interactions observed in education level and physical activity subgroups. Higher education levels are associated with a reduced risk of ED (46,47), potentially due to lower obesity rates among the highly educated (48-50). Physical activity has been linked to significant improvements in cardiovascular health and erectile function, with low and high activity levels reducing ED risk by over 20% in men aged 40 years and older (51-54). Physical activity improves sexual function by controlling cardiovascular risk factors, increasing endothelial-derived NO bioavailability, enhancing insulin sensitivity, reducing proinflammatory cytokines, and boosting testosterone levels (55,56). There are several notable strengths in this study. First, it leveraged a large, nationally representative cross-sectional sample from NHANES to examine and compare the associations between multiple surrogate markers of IR and the incidence of ED. This is the first study to report on the relationship between eGDR and ED. Furthermore, the analysis was rigorously adjusted for relevant confounding variables through multivariable logistic regression models. Finally, subgroup analyses were conducted to verify the consistency and stability of the association between eGDR and ED across different population strata. However, there were limitations. The cross-sectional design prevented causal inference. The observed associations should be interpreted as hypothesis-generating. Future longitudinal studies or randomized controlled trials are essential to confirm a causal relationship. Self-reported variables like erectile function, smoking, alcohol intake, and physical activity might introduce reporting biases. Some individuals with erectile issues might have been unaware of their condition, leading to potential misclassification. Information on the duration of diabetes was not available in the NHANES 2001–2004 public dataset; Thus, we were unable to explore the potential relationship between diabetes duration and ED risk and clarify the impact of diabetes chronicity on erectile function. Additionally, variables were assessed at baseline, lacking longitudinal data. Despite adjusting for many ED risk factors, residual confounders might remain due to database limitations and missing value exclusions. Lastly, the NHANES database represented the U.S. population, requiring further studies to verify these findings in other populations. Conclusions This study identified a significant inverse association between eGDR and ED, indicating that lower eGDR values were strongly linked to a higher likelihood of ED. Supplementary The article’s supplementary files as Available at https://tau.amegroups.com/article/view/10.21037/tau-2025-665/prf